Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholders' Equity [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Oct. 31, 2019 $ 203,317 $ 186,849,299 $ (181,817,263) $ 5,235,353 $ (422,975) $ 4,812,378
Beginning balance, shares at Oct. 31, 2019 20,331,754          
Stock option compensation to employees and directors 3,016,305 3,016,305 3,016,305
Stock options issued to consultants 156,914 156,914 156,914
Common stock issued upon exercise of stock options $ 511 121,759 122,270 122,270
Common stock issued upon exercise of stock options, shares 51,100          
Common stock issued in at-the-market offering, net of offering expenses $ 32,613 7,833,427 7,866,040 7,866,040
Common stock issued in at-the-market offering, net of offering expenses, shares 3,261,282          
Common stock issued pursuant to employee stock purchase plan $ 96 15,356 15,452 15,452
Common stock issued pursuant to employee stock purchase plan, shares 9,618          
Net loss (7,794,320) (7,794,320) (57,032) (7,851,352)
Ending balance, value at Jul. 31, 2020 $ 236,537 197,993,060 (189,611,583) 8,618,014 (480,007) 8,138,007
Ending balance, shares at Jul. 31, 2020 23,653,754          
Beginning balance, value at Apr. 30, 2020 $ 214,793 192,122,260 (187,049,899) 5,287,154 (464,904) 4,822,250
Beginning balance, shares at Apr. 30, 2020 21,479,335          
Stock option compensation to employees and directors 997,094 997,094 997,094
Stock options issued to consultants 44,705 44,705 44,705
Common stock issued upon exercise of stock options $ 72 18,468 18,540 18,540
Common stock issued upon exercise of stock options, shares 7,200          
Common stock issued in at-the-market offering, net of offering expenses $ 21,672 4,810,533 4,832,205 4,832,205
Common stock issued in at-the-market offering, net of offering expenses, shares 2,167,219          
Net loss (2,561,684) (2,561,684) (15,103) (2,576,787)
Ending balance, value at Jul. 31, 2020 $ 236,537 197,993,060 (189,611,583) 8,618,014 (480,007) 8,138,007
Ending balance, shares at Jul. 31, 2020 23,653,754          
Beginning balance, value at Oct. 31, 2020 $ 242,486 200,354,488 (191,835,618) 8,761,356 (496,983) 8,264,373
Beginning balance, shares at Oct. 31, 2020 24,248,695          
Stock option compensation to employees and directors 4,803,515 4,803,515 4,803,515
Common stock issued upon exercise of stock options $ 1,075 292,529 293,604 $ 293,604
Common stock issued upon exercise of stock options, shares 107,451         44,000
Common stock issued in at-the-market offering, net of offering expenses $ 28,064 10,805,651 10,833,715 $ 10,833,715
Common stock issued in at-the-market offering, net of offering expenses, shares 2,806,410          
Common stock issued pursuant to employee stock purchase plan $ 16 2,984 3,000 3,000
Common stock issued pursuant to employee stock purchase plan, shares 1,634          
Common stock issued in a public offering, net of offering expenses of $2,208,150 $ 42,858 20,248,996 20,291,854 20,291,854
Common stock issued in a public offering, net of offering expenses, shares 4,285,715          
Expired restricted stock award to employee $ (15,000) 15,000  
Expired restricted stock award to employee, shares (1,500,000)          
Stock options and warrants issued to consultants 421,182 421,182 421,182
Net loss (8,941,131) (8,941,131) (115,745) (9,056,876)
Ending balance, value at Jul. 31, 2021 $ 299,499 236,944,345 (200,776,749) 36,467,095 (612,728) 35,854,367
Ending balance, shares at Jul. 31, 2021 29,949,905          
Beginning balance, value at Apr. 30, 2021 $ 314,499 233,742,019 (196,442,760) 37,613,758 (559,107) 37,054,651
Beginning balance, shares at Apr. 30, 2021 31,449,905          
Stock option compensation to employees and directors 3,047,877 3,047,877 3,047,877
Expired restricted stock award to employee $ (15,000) 15,000  
Expired restricted stock award to employee, shares (1,500,000)          
Stock options and warrants issued to consultants 139,449 139,449 139,449
Net loss (4,333,989) (4,333,989) (53,621) (4,387,610)
Ending balance, value at Jul. 31, 2021 $ 299,499 $ 236,944,345 $ (200,776,749) $ 36,467,095 $ (612,728) $ 35,854,367
Ending balance, shares at Jul. 31, 2021 29,949,905